04 May 2022 : Clinical Research
Comparison of the Prevalence of Antibodies to SARS-CoV-2 in 9954 Recruits in the Korean Army Training Center with the General Korean Population of Equivalent Age Between September and November, 2020
Kwang Ho Mun1CDEF, Haebong Jang2ABG, Hwanyeong Jeong3BC, Jangkyu Choi4B, June-Woo Lee5A, Ah-Ra Kim
5CE, Su Hwan Kim5C, Sung Soon Kim6A, Donghyok Kwon 7B, Dohsik Minn8BC, Qyuen Park9ABG*
DOI: 10.12659/MSM.934926
Med Sci Monit 2022; 28:e934926
Table 2 Seroprevalence of SARS-CoV-2 antibodies in study subjects and Korean male population.
| Region | Study subjects | Korean male population | ||
|---|---|---|---|---|
| Seropositive | % | PCR positive | % | |
| Seoul | 4 | 0.20% (0.06–0.51) | 713 | 0.09% |
| Busan | 1 | 0.19% (0.00–1.08) | 62 | 0.02% |
| Daegu | 11 | 1.97% (0.99–3.42) | 1,031 | 0.51% |
| Incheon | 0 | 0.00% (0.00–0.74) | 96 | 0.04% |
| Gwangju | 0 | 0.00% (0.00–1.19) | 63 | 0.05% |
| Daejeon | 1 | 0.28% (0.00–1.53) | 37 | 0.03% |
| Ulsan | 1 | 0.50% (0.23–2.56) | 24 | 0.02% |
| Sejong | 0 | 0.00% (0.00–6.42) | 3 | 0.01% |
| Gyeonggi | 6 | 0.23% (0.1–0.50) | 757 | 0.07% |
| Gangwon | 0 | 0.00% (0.00–1.63) | 56 | 0.05% |
| Chungbuk | 1 | 0.32% (0.01–1.65) | 33 | 0.03% |
| Chungnam | 0 | 0.00% (0.00–0.91) | 85 | 0.05% |
| Jeonbuk | 1 | 0.33% (0.01–1.72) | 41 | 0.03% |
| Jeonnam | 0 | 0.00% (0.00–0.85) | 27 | 0.02% |
| Gyeongbuk | 4 | 0.80% (0.27–2.01) | 212 | 0.11% |
| Gyeongnam | 1 | 0.19% (0.00–1.04) | 40 | 0.02% |
| Jeju | 0 | 0.00% (0.00–1.68) | 13 | 0.03% |
| PCR – polymerase chain reaction test; SARS-CoV-2 – severe acute respiratory syndrome coronavirus 2. Data are expressed as n (%), and all of the subjects were Korean male adults, according to Statistics Korea. | ||||